Skip to main content

Endothelial Cell PAI-1 Production — Modulation by Malignant Cells in vitro

  • Chapter
Book cover Vascular Endothelium

Part of the book series: NATO ASI Series ((NSSA,volume 294))

  • 83 Accesses

Abstract

Plasminogen activator inhibitor-1 (PAI-1) is a single chain glycoprotein of approximately 50,000 Daltons which is synthesized by endothelial cells and hepatocytes. It is one of the many factors that endothelial cells (EC) secrete which are involved intimately in the maintenance of the haemostatic balance. In malignant states, especially those with widespread metastasis, this balance is frequently upset with a resulting increase in thromboembolic events. There is not one single easily identifiable pattern of changes that accounts for this increased risk, but disruption of the fibrinolytic system, in particular an increase in circulating PAI-1 concentration, is a common finding in patients with cancer. We wanted to assess the degree to which this might be due to an effect of malignant cells upon EC PAI-1 production.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Declerck PJ, et al. Measurement of plasminogen activator inhibitor 1 in biologic fluids with a murine monoclonal antibody-based enzyme-linked immunosorbent assay. Blood 71(1):220, 1988.

    PubMed  CAS  Google Scholar 

  2. Nand S, et al. Hemostatic abnormalities in untreated cancer: incidence and correlation with thrombotic and hemorrhagic complications. J Clin Oncol 5(12): 1998, 1987.

    PubMed  CAS  Google Scholar 

  3. Zurbon KH, et al. Investigations of coagulation of system and fibrinolysis in patients with disseminated adenocarcinomas and non-Hodgkin’s lymphomas. Oncology 47(5): 376, 1990.

    Article  Google Scholar 

  4. Mannucci PM, et al. Changes in fibrinolysis in patients with localized tumors. Eur J Cancer 26(2): 83, 1990.

    Article  PubMed  CAS  Google Scholar 

  5. ATCC Cell Lines & Hybridomas, 8th Edition 227, 1994, ATCC HB-8065, (Reference: Nature (Lond.)282:615, 1979.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer Science+Business Media New York

About this chapter

Cite this chapter

Zhen, L.W., Ling, M.C., Wickham, N. (1998). Endothelial Cell PAI-1 Production — Modulation by Malignant Cells in vitro . In: Catravas, J.D., Callow, A.D., Ryan, U.S. (eds) Vascular Endothelium. NATO ASI Series, vol 294. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-0133-0_45

Download citation

  • DOI: https://doi.org/10.1007/978-1-4899-0133-0_45

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4899-0135-4

  • Online ISBN: 978-1-4899-0133-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics